TrialAllergy2025

Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.

Sayantani B Sindher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.